← Leaderboards
Jared Michael Newton
Baylor College Of Medicine
$117,791
Attributed
$117,791
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.3K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$117,791 · 1
By mechanism
F31$117,791 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Vlad C Sandulache$3,056,791
- Ashok Veeraraghavan$2,262,661
- Kaiyi Li$3,229,176
- Carlos Caulin$5,933,951
- Fred A Pereira$10,135,185
Others in their field
Top investigators on “Head And Neck Squamous Cell Carcinoma”
- Jennifer R Grandis · University Of Pittsburgh At Pittsburgh$17,047,548
- Cun-Yu Wang · University Of California Los Angeles$14,843,475
- Lorraine J Gudas · Sloan-Kettering Institute For Cancer Res$11,559,006
- Qingyi Wei · University Of Texas Md Anderson Can Ctr$11,102,171
- Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh$10,353,289
- Xiao-Jing Wang · University Of California At Davis$9,895,933
Research focus
Head And Neck Squamous Cell CarcinomaImmuneEffectivenessGrowthHuman PapillomavirusAreaBaseAdverse EffectsAgonistCancer BiologyAnogenital CancerCancer PatientCancer TypeCareer DevelopmentCellsCervicalAntigen-Presenting CellsClinical InvestigationBiomedical EngineeringCombined Modality TherapyConditioningConventional TherapyCancer ImmunotherapyImmunogenic
Grant awards (3)
Immunomodulatory Nanoparticles in Combination with Immune Checkpoint Inhibitors for the Systemic Treatment of Immunosuppressive HPV Associated Oropharyngeal Cancer$28,091
F31 · FY2019 · DE · contact PI
Immunomodulatory Nanoparticles in Combination with Immune Checkpoint Inhibitors for the Systemic Treatment of Immunosuppressive HPV Associated Oropharyngeal Cancer$45,324
F31 · FY2018 · DE · contact PI
Immunomodulatory Nanoparticles in Combination with Immune Checkpoint Inhibitors for the Systemic Treatment of Immunosuppressive HPV Associated Oropharyngeal Cancer$44,376
F31 · FY2016 · DE · contact PI